ArticleFrontiers in oncology2026

Orelabrutinib and rituximab regimen combined with intravitreal methotrexate for treatment of primary vitreoretinal lymphoma: a case report and literature review.

Yuxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.